Ursodiol and Vascepa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ursodiol (ursodiol) and Vascepa (icosapent ethyl). Common drug interactions include arthralgia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Ursodiol and Vascepa. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.



On Jul, 16, 2026

21 people who take Ursodiol and Vascepa together, and have interactions are studied.

Ursodiol and Vascepa drug interactions.

What are the common drug interactions of Ursodiol and Vascepa, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Drug ineffective
  3. Eye pain
  4. General physical health deterioration (weak health status)
  5. Headache (pain in head)
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Neck pain
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  10. Spinal pain (pain in spine)

male:

  1. Fatigue (feeling of tiredness)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Drug hypersensitivity
  4. Dry mouth
  5. Dyspepsia (indigestion)
  6. Eating disorder
  7. Eosinophil count increased
  8. Excessive masturbation
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

What are the common drug interactions of Ursodiol and Vascepa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Anxiety
  4. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  5. Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)
  6. Compulsive sexual behaviour (unable to manage his/her sexual behaviour)
  7. Cough
  8. Drug hypersensitivity
  9. Dry mouth
  10. Dyspepsia (indigestion)

40-49:

n/a

50-59:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Coronary artery bypass
  3. Psoriasis (immune-mediated disease that affects the skin)

60+:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Asthenia (weakness)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Fatigue (feeling of tiredness)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  7. Drug hypersensitivity
  8. Eye pain
  9. Headache (pain in head)
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 19.05%
  2. Stress And Anxiety: 3 people, 14.29%
  3. Liver Disorder (liver diseases): 3 people, 14.29%
  4. Depression: 3 people, 14.29%
  5. Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 3 people, 14.29%
  6. Renal Cell Carcinoma (a kidney cancer): 2 people, 9.52%
  7. Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
  8. High Blood Pressure: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and Vascepa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ursodiol and Vascepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vascepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ursodiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vascepa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol and icosapent ethyl (the active ingredients of Ursodiol and Vascepa, respectively), and Ursodiol and Vascepa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: